These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 21881877)
21. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010. Pan IW; Ferguson SD; Lam S J Clin Neurosci; 2015 Oct; 22(10):1575-81. PubMed ID: 26122381 [TBL] [Abstract][Full Text] [Related]
22. The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study. Rapp M; Goeppert M; Felsberg J; Steiger HJ; Sabel M Br J Neurosurg; 2013 Aug; 27(4):430-5. PubMed ID: 23418781 [TBL] [Abstract][Full Text] [Related]
23. Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma. Zhang C; Wang X; Hao S; Su Z; Zhang P; Li Y; Song G; Yu L; Wang J; Ji N; Xie J; Gao Z World Neurosurg; 2016 Nov; 95():77-84. PubMed ID: 27485530 [TBL] [Abstract][Full Text] [Related]
24. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Simpson JR; Horton J; Scott C; Curran WJ; Rubin P; Fischbach J; Isaacson S; Rotman M; Asbell SO; Nelson JS Int J Radiat Oncol Biol Phys; 1993 May; 26(2):239-44. PubMed ID: 8387988 [TBL] [Abstract][Full Text] [Related]
25. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis. Wen J; Chen W; Zhu Y; Zhang P BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109 [TBL] [Abstract][Full Text] [Related]
26. Temozolomide during radiotherapy of glioblastoma multiforme : Daily administration improves survival. Nachbichler SB; Schupp G; Ballhausen H; Niyazi M; Belka C Strahlenther Onkol; 2017 Nov; 193(11):890-896. PubMed ID: 28197654 [TBL] [Abstract][Full Text] [Related]
27. Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update. Zullig LL; Sims KJ; McNeil R; Williams CD; Jackson GL; Provenzale D; Kelley MJ Mil Med; 2017 Jul; 182(7):e1883-e1891. PubMed ID: 28810986 [TBL] [Abstract][Full Text] [Related]
29. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification. Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992 [TBL] [Abstract][Full Text] [Related]
30. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis. Kozak KR; Moody JS Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771 [TBL] [Abstract][Full Text] [Related]
31. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121 [TBL] [Abstract][Full Text] [Related]
32. Survival improvements with adjuvant therapy in patients with glioblastoma. Jayamanne D; Wheeler H; Cook R; Teo C; Brazier D; Schembri G; Kastelan M; Guo L; Back MF ANZ J Surg; 2018 Mar; 88(3):196-201. PubMed ID: 28922698 [TBL] [Abstract][Full Text] [Related]
33. Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide. Topkan E; Topuk S; Oymak E; Parlak C; Pehlivan B Am J Clin Oncol; 2012 Jun; 35(3):284-9. PubMed ID: 21399487 [TBL] [Abstract][Full Text] [Related]
34. Effect of Surgical Intervention on Survival of Patients With Clinical N2 Non-Small Cell Lung Cancer: A Veterans' Affairs Central Cancer Registry (VACCR) Database Analysis. Ganti AK; Gonsalves W; Loberiza FR; Aldoss I; Batra R; Silberstein PT; Subbiah SP; Kessinger A Am J Clin Oncol; 2016 Apr; 39(2):142-6. PubMed ID: 24487419 [TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy. Matsuda M; Yamamoto T; Ishikawa E; Nakai K; Zaboronok A; Takano S; Matsumura A Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S54-60. PubMed ID: 21427185 [TBL] [Abstract][Full Text] [Related]
36. Glioblastoma patients' survival and its relevant risk factors during the pre-COVID-19 and post-COVID-19 pandemic: real-world cohort study in the USA and China. Qin L; Li H; Zheng D; Lin S; Ren X Int J Surg; 2024 May; 110(5):2939-2949. PubMed ID: 38376848 [TBL] [Abstract][Full Text] [Related]
37. Cancer incidence among patients of the U.S. Veterans Affairs Health Care System. Zullig LL; Jackson GL; Dorn RA; Provenzale DT; McNeil R; Thomas CM; Kelley MJ Mil Med; 2012 Jun; 177(6):693-701. PubMed ID: 22730846 [TBL] [Abstract][Full Text] [Related]
38. Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. Adams H; Chaichana KL; Avendaño J; Liu B; Raza SM; Quiñones-Hinojosa A World Neurosurg; 2013 Dec; 80(6):e237-43. PubMed ID: 23395851 [TBL] [Abstract][Full Text] [Related]
39. Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. Yabroff KR; Harlan L; Zeruto C; Abrams J; Mann B Neuro Oncol; 2012 Mar; 14(3):351-9. PubMed ID: 22241797 [TBL] [Abstract][Full Text] [Related]
40. Glioblastoma multiforme in the very elderly. Connon FV; Rosenthal MA; Drummond K Neurosurg Rev; 2016 Jan; 39(1):55-60; discussion 60-1. PubMed ID: 26208944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]